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Mutations in STRA6 Cause a Broad Spectrum of Malformations
Including Anophthalmia, Congenital Heart Defects,
Diaphragmatic Hernia, Alveolar Capillary Dysplasia, Lung
Hypoplasia, and Mental Retardation
Francesca Pasutto, Heinrich Sticht, Gerhard Hammersen, Gabriele Gillessen-Kaesbach,
David R. FitzPatrick, Gudrun Nu¨rnberg, Frank Brasch, Heidemarie Schirmer-Zimmermann,
John L. Tolmie, David Chitayat, Gunnar Houge, Lorena Ferna´ndez-Martı´nez, Sarah Keating,
Geert Mortier, Raoul C. M. Hennekam, Axel von der Wense, Anne Slavotinek, Peter Meinecke,
Pierre Bitoun, Christian Becker, Peter Nu¨rnberg, Andre´ Reis, and Anita Rauch
We observed two unrelated consanguineous families with malformation syndromes sharing anophthalmia and distinct
eyebrows as common signs, but differing for alveolar capillary dysplasia or complex congenital heart defect in one and
diaphragmatic hernia in the other family. Homozygosity mapping revealed linkage to a common locus on chromosome
15, and pathogenic homozygous mutations were identiﬁed in STRA6, a member of a large group of “stimulated by retinoic
acid” genes encoding novel transmembrane proteins, transcription factors, and secreted signaling molecules or proteins
of largely unknown function. Subsequently, homozygous STRA6 mutations were also demonstrated in 3 of 13 patients
chosen on the basis of signiﬁcant phenotypic overlap to the original cases. While a homozygous deletion generating a
premature stop codon (p.G50AfsX22) led to absence of the immunoreactive protein in patient’s ﬁbroblast culture, struc-
tural analysis of three missense mutations (P90L, P293L, and T321P) suggested signiﬁcant effects on the geometry of the
loops connecting the transmembrane helices of STRA6. Two further variations in the C-terminus (T644M and R655C)
alter speciﬁc functional sites, an SH2-binding motif and a phosphorylation site, respectively. STRA6mutations thus deﬁne
a pleiotropic malformation syndrome representing the ﬁrst human phenotype associated with mutations in a gene from
the “STRA” group.
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Clinical anophthalmia (AO) is the complete absence of
the eye and may be the most severe end of a clinical spec-
trum of ocular malformations including microphthalmia
(MO), which is a small eye usually deﬁned in terms of
corneal diameter or axial length.1 Estimates of the birth
prevalence of anophthalmia and microphthalmia from
well-maintained population-based registers are 14 and 3
per 100,000 births, respectively.1 Autosomal recessive or-
igin is likely in ∼10% of cases.2 CHX10 mutations have
been shown to underlie autosomal recessive isolated clin-
ical anophthalmia in two families3 and microphthalmia
with cataract and abnormalities of the iris,4 whereas syn-
dromic autosomal dominant anophthalmia has been as-
sociated with mutations in SOX2.5 According to a national
study on microphthalmia, anophthalmia, and coloboma,
33% of cases had one or more associated major malfor-
mations, and 21% had learning disabilities.1 As only a few
of the latter syndromal cases had features of recognized
entities, it was assumed that several new syndrome di-
agnoses are yet to be delineated in this group.
To increase the understanding of syndromic anophthal-
mia, we performed positional cloning in two unrelated
consanguineous families with new, apparently not yet re-
ported conditions, including clinical anophthalmia and
variable malformations of the lung, the heart, and the
diaphragm, as well as mental retardation. This work was
performed as part of our research study addressing the
genetics of mental retardation, which was approved by
the research ethics committee of the University of Er-
langen-Nuremberg.
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Figure 1. A and B, Pedigrees of the two families and segregation of the respective mutation (M). Arrows indicate the probands.
Individuals marked with asterisks participated in the genomewide linkage analysis. C and D, Examples of electropherograms of STRA6
mutations in families 1 (C) and 2 (D). WT p Wild type.
The proband in family 1 (IV:2 in ﬁg. 1A) was a female
infant born at 33 wk of gestation following a pregnancy
during which bilateral anophthalmia had been diagnosed
by ultrasound scan at 16 wk of gestation. She had normal
intrauterine growth, with a birth length of 49 cm (97th
percentile), weight 2,035 g (50th percentile), and head
circumference 32 cm (75th percentile). In the perinatal
period, bilateral clinical anophthalmiawas conﬁrmed. Ad-
ditional malformations were noted at that time: right-
sided pelvic kidney, circulatory nonrelevant pulmonic
valve stenosis, and persistent ductus arteriosus, whichwas
surgically closed at the age of 3 wk. When assessed at the
age of 2 mo, growth was normal, with the crown-to-heel
length (50 cm) and weight (3,200 g) at the age of 2 mo
corresponding to the 10th–25th percentile for prema-
turely born girls, whereas head circumference (35 cm) cor-
responded to the 25th–50th percentile. She hadmild facial
dysmorphism, with marked blepharophimosis with an
unusual trichoglyphic pattern of the eyebrows, which
were broad, ﬂaring, and only upward growing (ﬁg. 2E).
She had a broad nasal bridge, micrognathia, and large,
low-set ears (ﬁg. 2A and 2B). Cerebral magnetic resonance
imaging (MRI) showed no abnormality of brain structure
and showed visible optic nerves and chiasm. Mechanical
ventilatory support was required from birth, because of
persistent respiratory insufﬁciency. Chest CT at the age of
6 wk showed no evidence of pulmonary malformations,
lymphangiectasia, or interstitial lung disease. Open lung
biopsy performed at the age of 2.5 mo revealed a reduced
number of alveolar units and pulmonary capillary vessels
with thickening of the interalveolar septa, as well as me-
dial thickening of small pulmonary arteries with muscu-
larization, which are the key features of alveolar capillary
dysplasia (MIM 235680) (ﬁg. 2G) without misalignment
of lung vessels. She did not show any psychomotor de-
velopment and, despite high-dose steroid treatment, she
was extubated for only 13 d before dying at the age of 6
mo from respiratory insufﬁciency. The family history was
signiﬁcant. The parents are ﬁrst cousins of Turkish origin.
The paternal uncle of the proband, who was also married
to his half-cousin, had a daughter with bilateral ano-
phthalmia, who died at the age of 2 d from a complex
cyanotic congenital heart defect with atresia of the pul-
monary artery and single ventricle (IV:4 in ﬁg. 1A). She
had normal intrauterine growth, with a birth length of 51
cm (25th–50th percentile), weight 3,240 g (25th–50th per-
centile), and head circumference 36 cm (75th percentile).
Karyotype, metabolic screen, and cerebral and renal ul-
trasound all showed normal results. Parents consented to
postmortem examination of thoracic organs, which con-
ﬁrmed the single ventricle with atresia of the pulmonary
artery.
The proband in family 2 (IV:1 in ﬁg. 1B) was a 14-year-
old boy with bilateral clinical anophthalmia, diaphrag-
matic hernia, and profound mental retardation, with a
performance IQ estimated to be !20. He was the eldest
son of a healthy consanguineous couple of Turkish origin.
When assessed at the age of 13 years 3 mo, he had severe
short stature (height 123 cm [4.47 SD]; weight 21 kg
[BMI 2.95]) with relative preservation of head growth
(occipitofrontal circumference 51 cm [3rd percentile]). He
had no speech and had no obvious receptive language
skills. Although he used a wheelchair, he was able to take
a few steps when supported. He had both an atrial and a
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Figure 2. A–D, Frontal and lateral views of patient IV:2 of family 1 at age 6 mo (A and B) and patient IV:1 of family 2 at age 13
years (C and D). Note similar mild dysmorphism with broad, ﬂaring, and only upward-growing eyebrows; broad nasal bridge; large, low-
set ears; and receding chin. E and F, Close-up of right eyebrows of IV:2 of family 1 (E) and IV:1 of family 2 (F). G, Hematoxylin-eosin
staining of lung biopsy, showing deﬁciency in the number of alveolar units and pulmonary capillary vessels with thickening of the
interalveolar septa.
ventricular septal defect, which did not require any ther-
apy. Cerebral MRI performed at the age of 4 years showed
a structurally normal brain, apart from absent optic
nerves. He had mild facial dysmorphism with severe ble-
pharophimosis and an unusual trichoglyphic pattern of
both eyebrows similar to that seen in family 1 (ﬁg. 2F).
He had a broad nasal bridge, micrognathia, and large, low-
set ears (ﬁg. 2C and 2D). He had a healthy brother and
sister. His mother had had one termination of pregnancy
because of perceived high risk and another pregnancy that
was terminated at 23 wk gestation after a diagnosis of
bilateral anophthalmia and severe diaphragmatic hernia
on antenatal ultrasound scan (IV:3). The fetus showed
mild facial dysmorphism similar to that of the probands
in this family and family 1. Parents did not consent to
postmortem examination but agreed to skin biopsy for
ﬁbroblast culture.
To identify the underlying disease genes, a genome-
wide linkage scan was performed using the Affymetrix
GeneChip Human Mapping 10K SNP array Xba142 (ver-
sion 2.0) and both affected and unaffected individuals
from both families. The sex of each sample was veriﬁed
by counting heterozygous SNPs on the X chromosome.
Relationship errors were evaluated with the help of the
programGraphical Relationship Representation.6 The pro-
gram PedCheck was applied to detect Mendelian errors,7
and data for SNPs with such errors were removed from
the data set. Non-Mendelian errors were identiﬁed by use
of the program MERLIN,8 and unlikely genotypes for re-
lated samples were deleted. LOD score calculations were
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Figure 3. Graphic summaries of multipoint linkage analyses in families 1 and 2, performed using the Allegro program under the
assumption of autosomal recessive inheritance with full penetrance. A, Genomewide multipoint LOD scores of family 1, including
genotypes from individuals III:1–4, IV:1–3, and IV:5–6 (ﬁg. 1A), identifying a single locus on chromosome 15 with the expected
maximum LOD score of 2.9. B, Genomewide multipoint LOD scores of family 2, including genotypes from individuals III:1–2 and IV:1–
3 (ﬁg. 1B), identifying multiple loci on chromosomes 1, 4, 7, 8, and 15 with the expected maximum LOD score of 1.9. C, Summary
LOD scores including both families allowing also for locus heterogeneity (HLOD) revealing a single locus on chromosome 15 with a
maximum LOD and HLOD of 4.8.
performed using the Allegro program,9 under the assump-
tion of autosomal recessive inheritance with full pene-
trance. The parametric analysis unveiled the expected
maximum multipoint LOD score of 2.9 on chromosome
15 (q23-25.1) in family 1 for a region of ∼15 cM (ﬁg. 3A)
and multiple possible loci in family 2, including the same
locus on chromosome 15 with the expected maximum
LOD score of 1.9 (ﬁg. 3B). Parametric and nonparametric
linkage analysis of both families together revealed a single
maximum LOD score of 4.8 for the region 15q23-25.1,
which was also achieved when allowing for locus hetero-
geneity (HLOD) (ﬁg. 3C). Haplotypes were reconstructed
with ALLEGRO and were presented graphically with
HaploPainter.10 This latter program also reveals informa-
tive SNP markers as points of recombination between pa-
rental haplotypes. All data handling was performed using
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Figure 4. Haplotype analyses on chromosome 15q23-25.1, showing homozygous markers linked to the disease locus in family 1 (A)
and family 2 (B). According to the NCBI human genome overview page, build 35.1, the ﬂanking markers SNP_A-1511966 (rs1822829)
and SNP_A-1509050 (rs1077965) span a region of ∼12 Mb between 65.21 and 77.85 Mb from pter.
the graphical user interface ALOHOMORA.11 Haplotype
reconstruction showed homozygosity for two different al-
leles at the same 12-Mb region between markers SNP_A-
1511966 (rs1822829) and SNP_A-1509050 (rs1077965) in
affected children from both families (ﬁg. 4).
This critical region contained 1280 known and pre-
dicted genes annotated in the UCSC database. After eval-
uation of the available data on developmental expression
and function of each of the genes, we selected two for
mutational analysis. UACA (encoding uveal autoantigen
with coiled-coil domains and ankyrin repeats protein) was
selected because it plays an important role in the regu-
lation of stress-induced apoptosis and because it is ex-
pressed in heart and in choroid, retina, and eye muscles,
among other tissues, according to the SwissProt protein
database. STRA6 (FLJ12541; Stra for “stimulated by reti-
noic acid”) was chosen because of its involvement in the
retinoic acid pathway and its therefore likely role in mor-
phogenesis, as well as reported expression inmouse tissues
corresponding to affected organs in our patients.
Sequencing of UACA revealed no mutation in the pro-
bands of family 1 (IV:2) and 2 (IV:1). Sequence analysis
of all 20 exons (ﬁg. 5A) and intronic ﬂanking regions of
STRA6 revealed single-nucleotide variants in both fami-
lies. A homozygous missense mutation in exon 12,
c.878CrT (P293L), was found in the affected child IV:2
of family 1 (ﬁg. 1C). A homozygous frameshift muta-
tion leading to a premature stop codon (c.145_147delC;
p.G50AfsX22) in exon 4 was demonstrated in both af-
fected children of family 2 (ﬁg. 1D). Both mutations were
shown to cosegregate with the disease phenotype in the
respective families (ﬁg. 1A and 1B). After the identiﬁcation
of STRA6 mutations in these families, themutational anal-
ysis was extended using a cohort of 13 unrelated white
patients selected on the basis of having a severe eye mal-
formation and malformations of the diaphragm or one
of the latter associated with malformations of the lungs
or heart (table 1). This analysis led to the identiﬁcation
of four further homozygous amino acid changes (P90L,
T321P, T644M, and R655C) in STRA6 in three patients
(tables 1 and 2 and ﬁg. 5A). Parental heterozygosity for
the respective mutation was proved in families for which
parental samples were available (MWS1-EE and MWS4-
BE). Patient MWS6-BK carries two of these missense mu-
tations (P90L and T321P), both homozygously, but no
other family members were available for further analysis.
None of the mutations were found in a panel of 190
healthy, adult white control individuals. Further support
for the pathogenicity of the missense mutations was pro-
vided by the demonstration that each of the substituted
amino acids was evolutionarily conserved, which was
done using multiple sequence alignments by ClustalW
(ﬁg. 5B). RT-PCR analysis of RNA isolated from cultured
ﬁbroblasts of the affected aborted fetus (IV:3) from family
2, which harbored the premature stop mutation, showed
detectable levels of themutated STRA6 transcriptwith and
without puromycin treatment (ﬁg. 6A). Western blot anal-
ysis of protein extracted from these ﬁbroblasts was per-
formed using a rabbit polyclonal antibody raised to the
C-terminal region of STRA612 (kindly supplied by Pierre
Chambon). This showed absence of immunoreactive pro-
tein in the patient’s ﬁbroblasts (ﬁg. 6B). RT-PCR onnormal
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Figure 5. Location and conservation of mutated residues. A, Location of mutations along STRA6 genomic and protein schematic
representation, respectively. Transmembrane helices predicted by all three algorithms used are shown as dark gray boxes; helices predicted
only by one or two of the algorithms are shown as dotted light gray boxes. B, ClustalW multiple sequence alignments of human STRA6
regions to orthologues encompassing mutated residues. All these residues are evolutionary conserved. The respective substituted amino
acid is highlighted in blue.
adult human mRNAs from different tissues conﬁrmed the
broad expression pattern previously found in mice (ﬁg.
7A). Detailed analysis of distinct parts of an adult human
eye revealed expression in sclera, retina, retinal pigment
epithelium, and trabecular mashwork but not in choroid
and iris (ﬁg. 7B).
Both the function and the tertiary structure of STRA6
peptide are unknown. To explain the potential effects of
the missense mutations, we performed secondary struc-
ture analysis by use of three different prediction programs
(TMHMM,13 TMpred,14 and TopPred15), which suggested
that STRA6 has between 8 and 12 transmembrane helices.
Accordingly, three missense mutations (P90L, P293L, and
T321P) are predicted to be located in loops connecting
these transmembrane helices, whereas two missense mu-
tations (T644M and R655C) are located in the evolution-
ary conserved C-terminal region of the protein. Analysis
of the secondary structure outside the transmembrane seg-
ments was performed using a consensus secondary pre-
diction from the NPS@ server.16 This approach suggested
that the mutations P293L and P90L increase the extent of
helical structures in STRA6, resulting in an extension of
the transmembrane helix (P293L) (ﬁg. 6C) and the for-
mation of a novel helix within a loop (P90L). As a con-
sequence, the topology of the loops is altered, and nu-
merous conserved residues are brought into a different
orientation with respect to the membrane. Amino acid
T321 was also predicted to be located in an extremely
short loop (maximum length comprising residues 319–
326) connecting two transmembrane helices. As a con-
sequence of the T321P mutation, a rigid diproline-motif
(P320–P321) is generated that is probably incompatible
with the sterically demanding topology of this tight loop
(ﬁg. 6C). Thus, mutants P90L and T321P, observed ho-
mozygously in the same patient, are both expected to have
signiﬁcant effects on the secondary and tertiary structure
of the loops in STRA6.
In contrast, mutations T644M and R655C are predicted
by the ELM program17 to impair functional sites at the C-
terminal region. T644M alters the STAT5 Src Homology 2
(SH2) domain binding motif, YTLL, which triggers the
JAK2/STAT5 signaling cascade. STAT5 and related mem-
bers of the STAT family are activated in different tissues
by means of a series of ligands and are involved in inter-
feron signaling, development of the mammary gland, re-
sponse to growth hormone, and embryogenesis.18 R655C
alters the invariant arginine of the R-X-[ST] consensus se-
quence representing a phosphorylation site of proteinki-
nase A19 and therefore probably alters the successive signal
transduction pathways.
The phenotype of the three patients detected on the
follow-up mutation analysis shows remarkable overlap
with that of the initial cases, with bilateral clinical ano-
phthalmia and normal birth measurements as consistent
features. The healthy parents of patient MWS1-EE are
distantly related through a common great-great-grand-
parent. After a pregnancy remarkable for polyhydram-
nion, MWS1-EE was born at term with normal measure-
ments (weight 3,130 g [10th–25th percentile], length 50
cm [10th–25th percentile], and head circumference 35 cm
Table 1. Overview of Phenotype in Patients Investigated for STRA6 Mutations
Patient Mutation
Parental
Consanguinity Eye Lung Diaphragm Heart Palate Kidney Uterus
Age at
Death Other
Fam1-IV:2 P293L  b AO ACD  PSt, PDA  Pelvic  6 mo PTB 33 weeks, DD
Fam1-IV:4 NA  b AO   CHD,PA    2 d
Fam2-IV:1 p.G50AfsX22  b AO  CDH ASD, VSD    Alive at age 14 years, profound MR, SOS
Fam2-IV:3 p.G50AfsX22  b AO  CDH     TOP
MWS1-EE R655C  b AO Hypo DE 3 mo Inguinal hernia, severe hypotonia, failure to thrive
Brother NA  b AO   TAC-IV, RAA, PDA,
PA
   22 mo SOS
MWS4-BE T644M  b AO Hypo CDH b hydronephrosis Alive at age 3 mo
Brother NA  ? Hypo, unilo  TOF, PDA  Horseshoe  1 d Undescended testes, hypoplastic renal arteries
Sister NA  b AO Hypo, unilo  PDA, CoA   Dysplasia 1 d
MWS6-BK P90L, T321P  b AO Hypo CDH, DE PDA Hypo Bicornuate 1 d PTB 36 wk, Meckel diverticle
MWS2-FA   b Col  CDH     Skin patches, brittle hair
MWS3-KH   b MO  CDH     MO: extreme
MWS5-LR   Col  CDH    
RHP006.070   b MO  b DE     MO: extreme, MR
GM23728   b MO Hypo, unilo DE, hypo Hypo Pa, CoA Dysplastic Neonatal Abnormal cornea and iris
AvdW22260 -Twin1    Hypo CDH     1 d PTB (28 wk)
Twin 2    Hypo CDH  CP   1 d PTB (28 wk)
AS20861-FF264   ri
MO
 CDH     MO: max. diameter 9 mm at age 13 mo with inter-
nal, dense calciﬁcation within the globe, and a
larger, inferiorly located benign cyst measuring
2.5 cm; DD (11 mo level at age 13 mo)
CD50396   b AO Hypo DE VSD CP  Hypo, bicornuate 1 d Matthew-Woods syndrome, hypoplastic spleen, hy-
poplastic alae nasi
PM22479     CDH     Neonatal Suspected Donnai-Barrow syndrome (MIM 222448),
large omphalocele, hypoplasia of corpus cal-
losum, enlarged ventricles, extreme
hypertelomerism
Brother NA    CDH ASD b CLP   Neonatal Suspected Donnai-Barrow syndrome (MIM 222448),
hypoplasia of corpus callosum, enlarged ventri-
cles, extreme hypertelomerism
PB-E03_053   b MO  CDH      MO: severe, b inguinal hernia, sparse hair,
brachycephaly, MR, spasticity, alive at 10 years
NOTE.—ACD p alveolar capillary dysplasia; AO p anophthalmia; ASD p artrial septal defect; b p bilateral; CDH p congenital diaphragmatic hernia; CHDp congenital heart defect; C(L)Pp cleft (lip) palate; CoAp coarctation
of aorta; Col p coloboma; DD p developmental delay; DE p diaphragmatic eventration; Hypo p hypoplastic; MO p microphthalmia; MR p mental retardation; NA p not analyzed; Pa p pulmonary artery; PA p atresia of
pulmonary artery; PDA p persistent ductus arteriosus; PSt p pulmonic valve stenosis; PTB p preterm birth; RAA p right aortic arch; ri p right sided; SOS p postnatal shortness of stature; TAC p truncus arteriosus communis;
TOF p tetralogy of Fallot; TOP p termination of pregnancy; unilob p unilobular lung; VSD p ventricular septal defect.
www.ajhg.org The American Journal of Human Genetics Volume 80 March 2007 557
Table 2. Overview of STRA6 Mutations
Patient Exon
Alterationa
Genomic Protein
Fam1-IV:2 12 c.878CrT P293L
Fam2-IV:1 4 c.145-147delC p.G50AfsX22
Fam2-IV:3 4 c.145-147delC p.G50AfsX22
MWS1-EE 20 c.1963CrT R655C
MWS4-BE 20 c.1931CrT T644M
MWS6-BK 6, 13 c.269CrT, c.961ArC P90L, T321P
a All mutations were homozygous.
Figure 6. Characterization of mutations. A, STRA6 RT-PCR on cultured ﬁbroblast cells from the affected fetus (IV:3, family 2) and
from a healthy individual (C) grown in the absence and the presence of puromycin (p/p) as inhibitor of translation, respectively,
showing no evidence for early nonsense-mediated mRNA decay; () positive control, () negative control. B, Western blot analysis
of cultured ﬁbroblast protein cell extract showing a STRA6 protein band in two human healthy control lanes (indicated as “WT”) but
not in the two lanes with the homozygous mutant c.145_147delC (from IV:3, family 2). C, Model showing the effect of the P293L
mutation (right) on the STRA6 structure in comparison with the wild type (left). The membrane is indicated by a dotted line. The
transmembrane helix (A300-V319) that is proximal to the site of the mutation is shown in ribbon presentation, and the two adjacent
helices are indicated by cylinders. In the wild type, residue P293 represents the N-terminal cap of a helix starting at L294, whereas
the L293 present in the mutant allows an N-terminal extension of the helix, now starting at H291 and changing the topology of the
respective loop. Therefore, the P293L mutation is predicted to cause an extension of the helix by three residues, thus affecting the
structure and orientation of the respective loop. Moreover, it is important to note that V319 is also the N-terminal residue of an
extremely short loop (maximum predicted length between aa 319 and aa 326), in which a second mutation (T321P) has been identiﬁed.
[25th–50th percentile]). Because of respiratory insufﬁ-
ciency, ventilatory support was needed for 4 d. The boy
showed bilateral anophthalmia, left-sided diaphragmatic
eventration, and right-sided inguinal hernia. He had se-
vere hypotonia, poor feeding, and almost no weight gain
until he died at the age of 3 mo. No postmortem exam-
ination was performed. The older brother of MWS1-EE
also showed bilateral anophthalmia, with only remains of
nervi optici detected at autopsy. In addition, he had trun-
cus arteriosus communis type IV with right-sided aorta,
lack of pulmonary arteries, and lung supply by bronchial
arteries. He died from a thrombosis of the bronchial ar-
terial branches at the age of 22 mo. Although his birth
measurements at 36 wk gestation were normal (weight
2,300 g [10th percentile], length 46 cm [10th–25th per-
centile], and head circumference 33 cm [25th–50th per-
centile]), he had short stature at autopsy (length 78 cm
[3.26 SD] and head circumference 48 cm [25th–50th per-
centile]). He was not able to walk but could feed himself
and spoke in short sentences and thus showed no evi-
dence of mental retardation. Patient MWS4-BE is a female
infant who is the third child of seemingly unrelated
healthy parents. She was born at 38 wk gestation, weigh-
ing 3,180 g (50th percentile), with length of 47 cm (25th
percentile), and a head circumference of 34 cm (50th–75th
percentile). At birth, she was noted to have bilateral an-
ophthalmia, with a right-sided diaphragmatic hernia, pul-
monary hypoplasia, and bilateral hydronephrosis. Shewas
last assessed at the age of 3 mo. The family history was
signiﬁcant. The ﬁrst child was male and was born at 40
wk gestation, weighing 3,200 g (10th–25th percentile)
with a length of 49.5 cm (10th percentile). This infant
died at 24 h of age. At postmortem examination, pul-
monary hypoplasia, unilobular left lung, tetralogy of Fal-
lot, patent ductus arteriosus, undescended testes, horse-
shoe kidney, and hypoplastic renal arteries were noticed.
No mention was made of the eyes in the postmortem
report or neonatal record. The second child was female
and was born at 39 wk gestation, weighing 3,160 g (25th–
50th percentile). Bilateral anophthalmia was noted at
birth. This child also died in the ﬁrst 24 h of life. At post-
mortem examination, pulmonary hypoplasia with uni-
lobular lungs was noted, in addition to the severe eye
malformation. Patent ductus arteriosus, coarctation of the
aorta, and uterine dysplasia were also reported. Unfortu-
nately, no samples were available from the ﬁrst two chil-
dren. Patient MWS6-BK was the offspring of a marriage
between Pakistani ﬁrst cousins. The mother had two mid-
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Figure 7. Expression pattern of STRA6 determined by RT-PCR in
normal adult human (A) and eye (B) tissues. RPE p Retinal pig-
ment epithelium; TM p Trabecular meshwork.
trimester miscarriages. The girl was born at 36 wk gesta-
tion, with normal measurements (weight 2,750 g [25th–
50th percentile], length 47 cm [25th percentile], and head
circumference 33 cm [25th–50th percentile]. She died at
age 7 h from respiratory insufﬁciency with rapid deteri-
oration. Autopsy showed absent eyes with small palpebral
ﬁssures, left-sided diaphragmatic hernia, right-sided dia-
phragmatic eventration, bilateral severe lung hypoplasia,
structural normal heart with wide-open ductus arteriosus,
bicornuate uterus, small kidneys (6 and 5.7 g) with prom-
inent but microscopically normal adrenals (7.9 g), Meckel
diverticle, and prominent labia minora. Karyotyping re-
vealed homozygosity for the common pericentromeric in-
version of chromosome 9. Skeletal survey revealed no
abnormalities.
The phenotype of our patients with STRA6 mutations
shows overlap with that of the sib pair reported as having
“Matthew-Wood syndrome” (MIM 601186).20 However,
one of our patients, CD50396, who had the full clinical
picture described in this family, including cleft palate, hy-
poplastic alae nasi, hypoplastic spleen, and bicornuate
uterus, did not show a STRA6 mutation. This patient may
still harbor a STRA6 mutation outside the analyzed region
or may indicate locus heterogeneity for this disorder. Nev-
ertheless, there may be subtle differences in the facial dys-
morphisms—in particular, the shape of the nose and eye-
brows, the involvement of the palate, and the large head
size relative to body length—between patients with STRA6
mutations and those with Matthew-Wood syndrome, but
for these to be considered signiﬁcant, we will need to an-
alyze further cases. The combination of microphthalmia,
pulmonary hypoplasia, and diaphragmatic hernia has
been described in ﬁve patients with sporadic disease,21 all
of whom had intrauterine growth retardation, a feature
not seen in our patients with STRA6 mutations. The
combination of severe microphthalmia, Fallot tetralogy,
and diaphragmatic hernia has been reported in a child
with de novo balanced chromosomal translocation
(1;15)(q41;q21.2),22 but the breakpoint on chromosome
15 is located several bands proximal to the STRA6 locus.
These sporadic cases and cases of Matthew-Wood syn-
drome may not be associated with STRA6 mutations but
are likely to be caused by a gene from the same pathway.
STRA6 belongs to a novel group of retinoic acid (RA)–
inducible genes that are likely to be direct targets of the
retinoid receptors, such as RXRa and RARg.23 STRA6 is
predicted to encode a highly hydrophobic transmembrane
protein, which does not display similarities with other
known integral membrane proteins. Immunohistochem-
ical and RNA in situ hybridization analyses revealed site-
and stage-speciﬁc expression of Stra6 during murine em-
bryonic development. In placenta, Stra6 is prominently
expressed in the region of exchanges between maternal
and embryonic circulations (i.e., yolk sac and labyrinthine
zone of mature placenta). During embryogenesis, Stra6 is
strongly expressed in the periocular mesenchyme, in the
developing eyes, in respiratory mesenchymes, and in re-
spiratory/bronchial epithelium, as well as in the devel-
oping CNS (meninges, cranial ganglia, choroid plexi, and
brain microvasculature) and in different embryonic gut
derivatives (the epithelium of the pharyngeal pouches,
mesenchyme of the esophagus, stomach, intestine, and
rectum). In adult organs, it is strongly expressed at the
level of blood-organ barriers. These barriers are made of
epithelial and endothelial cells connected by tight junc-
tions and play a role in limiting passive diffusion of
chemicals, as well as in the facilitative transport of many
nutrients. The high expression of Stra6 in 16 of these dif-
ferent barriers, together with its localization in the basal
region of the Sertoli cell plasmamembrane, suggested that
it may function as a component of an as-yet-unidentiﬁed
transport machinery.12,23
The RA signaling pathway is complex and incompletely
understood. RA appears to directly regulate 1500 pro-
teins.24 RA signaling is known to be important in nor-
mal lung and alveolar development.25 The developing
diaphragm,26,27 heart,28 and CNS24 also strongly depend on
proteins associated with the metabolism and binding of
retinoids. It is interesting that the homozygous null mu-
tation was compatible with life (family 2), whereas the
patients with missense mutations all died of respiratory
insufﬁciency (family 1: MWS1-EE, MWS4-BE, and MWS6-
BK). The assembly of an altered protein into the mem-
brane thus may bemore deleterious than the total absence
of the protein. Alveolar dysplasia and pulmonary hypo-
plasia may be the result of an impaired RA signal trans-
duction resulting in abnormal levels of elastin production,
which is essential for alveolization.25
Congenital diaphragmatic hernia (CDH) is an important
component of the phenotype in the STRA6 mutation-pos-
itive cases, and, in this malformation, the etiology is un-
clear in most isolated and syndromal cases. CDH has an
incidence of 1 in 3,000 births and a high mortality rate
of ∼33%–58%.29 Many cytogenetic anomalies have been
described in CDH involving almost every chromosome
but most commonly chromosome 15.30 A 5-Mb critical
interval has been deﬁned molecularly on 15q26.1-q26.2,31
but no causal mutations in individual genes within this
region have been identiﬁed in CDH cases.32 The only gene
that has been implicated in diaphragmatic and lung de-
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velopment in humans is FOG2, or ZFPM2 (8q23),33 which
was foundmutated in a single deceased childwithbilateral
pulmonary hypoplasia and abnormally muscularized di-
aphragm but also in some patients with Fallot tetralogy.34
Alveolar capillary dysplasia is a rare but probably under-
diagnosed cause of persistent pulmonary hypertension of
the neonate, usually resulting in death within 4–6wk after
birth.35 It will be interesting to investigate isolated cases
for STRA6 mutations.
In summary, we show that homozygous mutations in
STRA6 cause a pleiotropic,multisystemmalformation syn-
drome characterized by bilateral anophthalmia, mild fa-
cial dysmorphism, normal intrauterine growth, early le-
thality in most cases, and a variety of malformations of
the lungs, diaphragm, heart, and urogenital system. Pro-
found mental retardation and short stature with relatively
large head were present in the one patient with long-term
survival. This STRA6 anophthalmia syndrome shows phe-
notypic overlap with Matthew-Wood syndrome, which
may be distinct, however, in facial dysmorphism and in-
volvement of the palate. Very preliminary genotype-phe-
notype correlation suggests that missense mutations may
be associated with early lethality due to respiratory in-
sufﬁciency, whereas truncating mutation may be com-
patible with long-term survival and normal lung function.
Further studies are necessary to elucidate whether
STRA6 and related genes from the RA pathway are also
involved in the pathogenesis of other types of syndromal
or isolated anophthalmia, diaphragmatic hernia, and al-
veolar capillary dysplasia.
Note added in proof.—STRA6 was just identiﬁed as the
long-sought membrane receptor for retinol binding pro-
tein that mediates cellular uptake of vitamin A.36
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